A 20-year-old woman was receiving a multi-agent chemotherapeutic regimen for Hodgkin disease, stage IIB. After the third round of treatment, she presented for medical care because of rapidly growing pedal lesions that made walking painfully difficult.
What would be the best initial intervention in this case?